{"news_desk": null, "print_page": null, "section_name": "Blogs", "subsection_name": null, "byline": {"original": "By DEALBOOK", "person": [{"role": "reported", "firstname": "Dealbook", "organization": "", "rank": 1}]}, "abstract": "Twitter Chief\u2019s Exit Sparks Deal Speculation | I.M.F. Pulls Team From Greece Bailout Talks | Murdoch to Hand Over Media Empire to Sons | Axovant\u2019s Market Debut Renews Biotech Bubble Worries", "type_of_material": "Blog", "word_count": "1880", "lead_paragraph": null, "pub_date": "2015-06-12T07:16:51Z", "document_type": "blogpost", "slideshow_credits": null, "headline": {"main": "Morning Agenda: Twitter Chief&#8217;s Exit Sparks Deal Speculation", "kicker": "News"}, "snippet": "Twitter Chief\u2019s Exit Sparks Deal Speculation | I.M.F. Pulls Team From Greece Bailout Talks | Murdoch to Hand Over Media Empire to Sons | Axovant\u2019s Market Debut Renews Biotech Bubble Worries", "multimedia": [], "web_url": "http://news.blogs.nytimes.com/2015/06/12/morning-agenda-twitter-chiefs-exit-sparks-deal-speculation/", "keywords": [{"rank": "1", "value": "Bain, Adam", "name": "persons"}, {"rank": "2", "value": "Costolo, Dick", "name": "persons"}, {"rank": "3", "value": "Dorsey, Jack", "name": "persons"}, {"rank": "4", "value": "Murdoch, James R", "name": "persons"}, {"rank": "5", "value": "Murdoch, Lachlan", "name": "persons"}, {"rank": "6", "value": "Murdoch, Rupert", "name": "persons"}, {"rank": "7", "value": "Noto, Anthony J", "name": "persons"}, {"rank": "1", "value": "Greece", "name": "glocations"}, {"rank": "1", "value": "Axovant Sciences Ltd.", "name": "organizations"}, {"rank": "2", "value": "Fox Entertainment Group Inc", "name": "organizations"}, {"rank": "3", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "4", "value": "International Monetary Fund", "name": "organizations"}, {"rank": "5", "value": "Twitter", "name": "organizations"}, {"rank": "1", "value": "Alzheimer's Disease", "name": "subject"}, {"rank": "11", "value": "Venture Capital", "name": "subject"}, {"rank": "2", "value": "Appointments and Executive Changes", "name": "subject"}, {"rank": "3", "value": "Banking and Financial Institutions", "name": "subject"}, {"rank": "4", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "5", "value": "European Sovereign Debt Crisis (2010- )", "name": "subject"}, {"rank": "6", "value": "Hedge Funds", "name": "subject"}, {"rank": "7", "value": "Initial Public Offerings", "name": "subject"}, {"rank": "8", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "9", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "10", "value": "Shareholder Rights and Activism", "name": "subject"}], "blog": [], "_id": "557ac00b38f0d82bd01b5238", "source": "The New York Times"}